Cancer Health Treatment Update 2023 Chemotherapy Shortage Did Not Cause More Cancer Deaths Shortages led to a 2.7% decrease in use of two common platinum-based chemotherapies: cisplatin and carboplatin. New Drug Stops Cancer Cells From Evading Immune System Detection Colorado University’s Eduardo Davila found that DNA-PK inhibitors can block a tumor cell’s ability to escape T-cell detection. U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk Alcohol consumption is the third leading preventable cause of cancer in the U.S., but less than half of Americans recognize it as a risk. Studies Highlight Progress in Preventing and Treating Blood Cancers and Pre-Cancerous Conditions Advances reported as annual ASH conference show promise for patients with smoldering multiple myeloma, chronic lymphocytic leukemia and acute myeloid leukemia. Cancer Health Winter 2025 Check out our new print edition! Advertisement News From SABCS 2024 News about the latest research on breast cancer biology, prevention and treatment from the San Antonio Breast Cancer Symposium. News From ASH 2024 Blood cancer news from the American Society for Hematology Annual Meeting and Exhibition. NIH Officials Assess Threat of H5N1 Flu People should find a balance between enhanced vigilance and “business as usual” with regard to bird flu, health officials urge. Newsfeed 2023 Chemotherapy Shortage Did Not Cause More Cancer Deaths Dana-Farber Launches Center for RAS Therapeutics to Target RAS Oncogene U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk Combating Chemotherapy Resistance in Cancer Blog: National Cancer Institute NCI Director Kimryn Rathmell Marks One Year in Cancer Research and Much to Celebrate When Cisplatin Isn’t an Option for Head and Neck Cancers, Here’s a Possible Treatment Treatment Strategy for ecDNA-Driven Tumors Shows Potential A “Living Medicine:” Engineered E. coli Shrink Tumors in Mice Newsfeed 2023 Chemotherapy Shortage Did Not Cause More Cancer Deaths Dana-Farber Launches Center for RAS Therapeutics to Target RAS Oncogene U.S. Surgeon General Issues New Advisory on Link Between Alcohol and Cancer Risk Combating Chemotherapy Resistance in Cancer Blog: National Cancer Institute NCI Director Kimryn Rathmell Marks One Year in Cancer Research and Much to Celebrate When Cisplatin Isn’t an Option for Head and Neck Cancers, Here’s a Possible Treatment Treatment Strategy for ecDNA-Driven Tumors Shows Potential A “Living Medicine:” Engineered E. coli Shrink Tumors in Mice

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: